HKEx Stock Code: 01093English|繁體|简体

For 2019 Interim Results

  • Sales of approximately RMB11,178 million, representing a 27.6% growth year-on-year;
  • Profit attributable to shareholders of approximately RMB1,878 million, representing a 24.8% growth year-on-year.

Highlight - 2019 Interim

Revenue
RMB11,178 mn, +27.6%
Profit attributable to shareholders
RMB1,878 mn, +24.8%
Basic earnings per share
RMB30.13 cents, +25.0%

Corporate Governance

Corporate Governance

Financial Calendar

Nov
18
Nov
18
Aug
19
Aug
19
May
27
May
21
May
21
Mar
18
Mar
18

Financial Reports

Financial Reports

Financial Summary

Financial Summary

IR Contacts

Address : Suite 3206, 32/F, Central Plaza,
18 Harbour Road, Wanchai, Hong Kong
Tel : (852) 2500 3144
Fax : (852) 2802 4552
E-mail : ir@cspc.hk
© Copyright 2019 CSPC Pharmaceutical Group Limited. All Rights Reserved.